Stock BICTF BIOCURE TECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Biocure Technology Inc. OTC Markets

Equities

BICTF

CA09075T1075

Uranium

Market Closed - OTC Markets
Other stock markets
 07:30:00 2023-12-12 am EST 		5-day change 1st Jan Change
0.07 USD -.--% Intraday chart for Biocure Technology Inc. -.--% -.--%
2023 Biocure Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Atriva Therapeutics GmbH announced that it expects to receive $15 million in funding CI

Business Summary

Biocure Technology Inc. is a biopharmaceutical company. The Company is engaged in development and commercialization of various biopharmaceutical technologies relating to uses of recombinant and ranibizumab. The Company is comprised of scientists specializing in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. In addition, the Company is developing Biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.

Managers

Managers TitleAgeSince
Sang-Mok Lee FOU
 Founder 58 07-08-23
Konstantin Lichtenwald DFI
 Director of Finance/CFO 40 18-02-28
Björn Cochlovius PSD
 President 56 21-07-21
Collin Kim BRD
 Director/Board Member 58 15-08-27

Members of the board

Members of the board TitleAgeSince
Sang-Mok Lee FOU
 Founder 58 07-08-23
Konstantin Lichtenwald DFI
 Director of Finance/CFO 40 18-02-28
Collin Kim BRD
 Director/Board Member 58 15-08-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 94,000,537 93,896,356 ( 99.89 %) 0 99.89 %

Shareholders

NameEquities%Valuation
Sang-Mok Lee
29.06 %
27,317,506 29.06 % 409 763 $
Collin Kim
3.552 %
3,339,181 3.552 % 50 088 $
Konstantin Lichtenwald
2.845 %
2,674,181 2.845 % 40 113 $
Simon Cheng
0.0559 %
52,500 0.0559 % 788 $
Yee Sing Cheng
0.000000 %
0 0.000000 % - $

Company contact information

Biocure Technology, Inc.

1055 West Hastings Street Suite 300

V6E 2E9, Vancouver

+604-609-7146

http://www.biocuretech.com
address Biocure Technology Inc.(BICTF)

Sector

Energy
Uranium
Uranium
Uranium
Other Uranium

Sector Other Uranium

1st Jan change Capi.
CAMECO CORPORATION Stock Cameco Corporation
+17.98% 21.37B
URANIUM ENERGY CORP. Stock Uranium Energy Corp.
+7.97% 2.79B
CGN MINING COMPANY LIMITED Stock CGN Mining Company Limited
+13.37% 1.89B
YELLOW CAKE PLC Stock Yellow Cake plc
+1.94% 1.7B
CENTRUS ENERGY CORP. Stock Centrus Energy Corp.
-23.60% 665M
URANIUM ROYALTY CORP. Stock Uranium Royalty Corp.
-9.27% 284M
ELEVATE URANIUM LTD Stock Elevate Uranium Ltd
+3.37% 92.53M
GOVIEX URANIUM INC. Stock GoviEx Uranium Inc.
-40.00% 53.43M
Other Uranium
  1. Stock Market
  2. Equities
  3. CURE Stock
  4. BICTF Stock
  5. Company Biocure Technology Inc.